No association between VAPB mutations and familial or sporadic ALS in Sweden, Portugal and Iceland

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 14, Issue 7-8, 2013, Pages 620-627

  Ingre, Caroline ^a,b   Pinto, Susana ^d   Birve, Anna ^a   Press, Rayomand ^b   Danielsson, Olof ^c   De Carvalho, Mamede ^d   Gudmundsson, Grétar ^e   Andersen, Peter M ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF LISBON   (Portugal)

^e LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

ALS; Oligomutant; Risk factor; SOD1; VAPB

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FAMILIAL DISEASE; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOSITY; HUMAN; ICELAND; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PORTUGAL; PRIORITY JOURNAL; RELATIVE; SOD1 GENE; SWEDEN; VAPB GENE;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; COHORT STUDIES; FEMALE; HUMANS; ICELAND; MALE; MIDDLE AGED; MUTATION, MISSENSE; PEDIGREE; PORTUGAL; SWEDEN; VESICULAR TRANSPORT PROTEINS;

EID: 84887498238     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2013.822515     Document Type: Article

References (38)

1. Hentati F, Ben Hamida C. H ereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Conditions combining a bilateral pyramidal syndrome with limb and bulbar amyotrophy. Brain. 1990; 113:347-63.
2. Andersen PM, Nilsson P, Ala-Hurula V, Keranen ML, Tarvainen I, Haltia T, et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in Cu/Zn superoxide dismutase. Nat Genet. 1995; 10:61-6.
3. Andersen PM, Al-Chalabi A. C linical genetics of amyotrophic lateral sclerosis: what do we really know Nat Rev Neurol. 2011; 7:603-15.
4. Felbecker A, Camu W, Waldmanis PN, Sperfeld A D, Waibel S, Steinbach P, et al. Four familial ALS pedigrees discordant for two SOD1 mutations: are all SOD1 mutations pathogenic J Neurol Neurosurg Psychiatry. 2010; 81:572-7.
5. Nishimura AL, Mitne-Neto M, Silva H C, Richieri-Costa A, Middelton S, Cascio D, et al. A mutation in the vesicletraffi cking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet. 2004; 75:822-31.
6. Marques V D, Barreira AA, Davis M B, Abou-Sleiman PM, Silva WA Jr, Zago MA, et al. Expanding the phenotypes of the Pro56Ser VAPB mutation: proximal SMA with dysautonomia. Muscle Nerve. 2006; 34:731-9.
7. Funke A D, Esser M, Krü ttgen A, Weis J, Mittne-Neto M, Lazar M, et al. The p.P56S mutation in the VAPB gene is not due to a single founder: the fi rst European case. Clin Genet. 2010; 77:302-3.
8. Millecamps S, Salachas F, Cazeneuve C, Gordon P, Bricka B, Camuzat A, et al. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet. 2010; 47:554-60.
9. Landers J E, Leclerc AL, Shi L, Virkud A, Cho T, Maxwell MM, et al. New VAPB deletion variant and exclusion of VAPB mutations in familial ALS. Neurology. 2008; 70:1179-85.
10. Nishimura Y, Hayashi M, Inada H, Tanaka T. M olecular cloning and characterization of mammalian homologues of vesicle-associated membrane protein-associated (VAMPassociated) proteins. Biochem Biophys Res Commun. 1999; 254:21-6.
11. W eir M L, Klip A, Trimble W S. I dentifi cation of a human homologue of the vesicle-associated membrane protein (VAMP)-associated protein of 33 kDa (VAP-33): a broadly expressed protein that binds to VAMP. Biochem J. 1998; 333:247-51.
12. Soussan L, Burakov D, Daniels M P, Toister-Achituv M, Porat A, Yarden Y, et al. ERG30, aVAP-33-related protein, functions in protein transport mediated by COPI vesicles. J Cell Biol. 1999; 146:301-11.
13. Teuling E, Ahmed S, Haasdijk E, Demmers J, Steinmetz MO, Akhmanova A, et al. Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. J Neurosci. 2007; 27:9801-15.
14. Anagnostou G, Akbar M T, Paul P, Angelinetta C, Steiner TJ, de Belleroche J. Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord. Neurobiol Aging. 2010; 31:969-85.
15. Chen HJ, Anagnostou G, Chai A, Withers J, Morris A, Adhikaree J, et al. Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis. J Biol Chem. 2010; 285:40266-81.
16. van Blitterswijk M, van Es MA, Koppers M, van Rheenen W, Medic J, Schelhaas HJ, et al. VAPB and C9orf72 mutations in one familial amyotrophic lateral sclerosis patient. Neurobiol Aging. 2012; 33:2950e1-4.
17. de Roy P G. H elsinki and the Declaration of Helsinki. W orld Med J. 2004; 50:9-11.
18. Brooks BR. E l Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ' Clinical limits of amyotrophic lateral sclerosis ' workshop contributors. J Neurol Sci. 1994; 124(Suppl):96-107.
19. Byrne S, Bede P, Elamin M, Kenna K, Lynch C, McLaughlin R, et al. Proposed criteria for familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011; 12:157-9.
20. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. Nat Methods. 2010; 7:248-9.
21. Kumar P, Henikoff S, Ng PC. P redicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009; 4:1073-81.
22. Bromberg Y, Rost B. SNAP: predict effect of non-synonymous polymorphisms on function. Nucleic Acids Res. 2007; 35:3823-35.
23. Ferrer-Costa C, Gelpi JL, Zamakola L, Parraga I, de la Cruz X, Orozco M. PMUT: a web-based tool for the annotation of pathological mutations on proteins. Bioinformatics. 2005; 21:3176-8.
24. Capriotti E, Fariselli P, Calabrese R, Casadio R. P redicting protein stability changes from sequences using support vector machines. Bioinformatics. 2005; 21(Suppl 2):54-8.
25. Capriotti E, Fariselli P, Casadio R. I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res. 2005; 33:306-10.
26. Capriotti E, Calabrese R, Casadio R. P redicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information. Bioinformatics. 2006; 22:2729-34.
27. Altschul S F, Madden TL, Shaffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997; 25:3389-402.
28. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 2011; 7:539.
29. McWilliam H, Li W, Valentin F, Squizzato S, Paern J, et al. A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res. 2010; 38:695-9.
30. Letunic I, Doerks T, Bork P. S MART 7: recent updates to the protein domain annotation resource. Nucleic Acids Res. 2012; 40:302-5.
31. Schultz J, Milpetz F, Bork P, Ponting CP. S MART, asimple modular architecture research tool: identifi cation of signalling domains. Proc Natl Acad Sci USA. 1998; 95:5857-64.
32. Sigrist CJ, Cerutti L, de Castro E, Langendijk-Genevaux PS, Bulliard V, Bairoch A, et al. PROSITE, aprotein domain database for functional characterization and annotation. Nucleic Acids Res. 2010; 38:161-6.
33. den Dunnen JT, Antonarakis SE. M utation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat. 2000; 15:7-12.
34. Agresti A. A Survey of Exact Inference for Contingency Tables. Statist Sci. 1992; 7:131-53.
35. Suzuki H, Kanekura K, Levine T P, Kohno K, Olkkonen VM, Aiso S, et al. ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of coexpressed wild-type VAPB. J Neurochem. 2009; 108:973-85.
36. Tsuda H, Han SM, Yang Y, Tong C, Lin YQ, Mohan K, et al. The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors. Cell. 2008; 133:963-77.
37. Conforti F L, Sprovieri T, Mazzei R, Ungaro C, Tessitore A, Tedeschi G, et al. Sporadic ALS is not associated with VAPB gene mutations in southern Italy. J Negat Results Biomed. 2006; 5:7.
38. van Blitterswijk M, van Es M A, Hennekam E A, Dooijes D, van Rheenen W, Medic J, et al. Evidence for oligogenic basis of amyotrophic lateral sclerosis. Hum Mol Genet. 2012; 21:3776-84.